KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Equity (2018 - 2025)

Historic Return on Equity for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.52%.

  • Amneal Pharmaceuticals' Return on Equity fell 24600.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year decrease of 24600.0%. This contributed to the annual value of 1.65% for FY2024, which is 21300.0% up from last year.
  • Amneal Pharmaceuticals' Return on Equity amounted to 0.52% in Q3 2025, which was down 24600.0% from 0.42% recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Return on Equity high stood at 5.52% for Q1 2024, and its period low was 1.62% during Q1 2023.
  • In the last 5 years, Amneal Pharmaceuticals' Return on Equity had a median value of 0.0% in 2022 and averaged 0.19%.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Return on Equity surged by 71400bps in 2024, and later crashed by -57900bps in 2025.
  • Amneal Pharmaceuticals' Return on Equity (Quarter) stood at 0.05% in 2021, then crashed by -2600bps to 1.35% in 2022, then skyrocketed by 58bps to 0.56% in 2023, then skyrocketed by 230bps to 0.73% in 2024, then plummeted by -171bps to 0.52% in 2025.
  • Its Return on Equity was 0.52% in Q3 2025, compared to 0.42% in Q2 2025 and 0.27% in Q1 2025.